Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-04-08 00:00:00 ET · period of report 2024-04-04 · accession 0001415889-24-010503 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-08 | 2024-04-08 | KNSA | Tessari Eben | COO | M - OptEx | — | +2,726 | 126.8K | +2% | — |
| D | 2024-04-08 | 2024-04-08 | KNSA | Tessari Eben | COO | F - Tax | $17.90 | -801 | 126.0K | -0.6% | -$14.3K |
| D | 2024-04-08 | 2024-04-08 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -2,726 | 9,573 | -22% | $0 |
| DM | 2024-04-08 | 2024-04-04 | KNSA | Tessari Eben | COO | A - Grant | $0.00 | +48.9K | 36.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-04-08 | M | A | 2,726 | — | 126,825 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2024-04-08 | F | D | 801 | $17.90 | 126,024 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2024-04-08 | M | D | 2,726 | $0.00 | 9,573 | D | — · — to — | 2,726 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022. |
| 4 | Derivative | Restricted Share Unit | 2024-04-04 | A | A | 6,981 | $0.00 | 12,299 | D | — · — to — | 6,981 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F5) The RSUs vest over a four year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter. |
| 5 | Derivative | Performance Share Unit | 2024-04-04 | A | A | 5,585 | $0.00 | 5,585 | D | — · — to 2034-03-31 | 5,585 Class A Common Share | (F3) Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Common Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee. (F4) Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Common Share of the Issuer no later than January 30, 2027, unless such date falls on a non-business date, in which case the next business date shall apply. |
| 6 | Derivative | Share Option | 2024-04-04 | A | A | 36,300 | $0.00 | 36,300 | D | $18.06 · — to 2034-03-31 | 36,300 Class A Common Share | (F2) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal month installments thereafter. The vesting commencement date is April 1, 2024. |